Cargando…
Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic
Autores principales: | Ghosh, Amerta, Dutta, Koel, Tyagi, Kanika, Gupta, Ritesh, Misra, Anoop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202839/ https://www.ncbi.nlm.nih.gov/pubmed/32416526 http://dx.doi.org/10.1016/j.dsx.2020.05.010 |
Ejemplares similares
-
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
por: Ghosh, Amerta, et al.
Publicado: (2020) -
Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases
por: Mishra, Abha, et al.
Publicado: (2021) -
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
por: Ghosal, Samit, et al.
Publicado: (2020) -
Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India
por: Tyagi, Kanika, et al.
Publicado: (2021) -
Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification
por: Misra, Anoop, et al.
Publicado: (2021)